Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Do you offer hypofractionation or RNI for a pT1N0 high-grade primary neuroendocrine carcinoma of the breast?
Answer from: Radiation Oncologist at Community Practice
Hypofractionation with a boost, yes. No RNI if the SNLN is negative.
Sign In
or
Register
to read more
30923
Related Questions
What is the maximum dose that you would give to residual unresectable gross disease in the axilla in the setting of recurrent breast cancer s/p ALND?
Do you boost a breast cavity for a high Ki-67 index in the absence of other risk factors?
How do you approach post-lumpectomy surveillance in male breast cancer patients without BRCA or other mutations?
What is your preferred comprehensive nodal irradiation approach in non-metastatic breast cancer patients with underlying respiratory diseases or poor baseline respiratory function in light of the findings from the RadComp Trial?
When using surface image-guidance for breast radiation, how do you accommodate for changes in anatomy?
What radiation fields would you recommend in a young patient with luminal B histology and ITCs in a single sentinel node?
How do you treat a patient with early-stage breast cancer s/p lumpectomy and oncoplastic reconstruction with a positive margin, when re-excision is not feasible?
How, if at all, does your practice differ between male and female breast cancer patients with respect to the use of bolus?
Do you omit PMRT for patients who would have been eligible for NSABP B-51, but are found to have significant pure LVSI only, without stromal carcinoma, after neoadjuvant chemotherapy?
How do you approach reirradiation in a patient who underwent breast-conserving surgery for recurrent breast cancer after initial lumpectomy and APBI?